Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Protective Role of Kupffer Cells in Acetaminophen-Induced Hepatic Injury in Mice

作者:Cynthia Ju, Timothy P. Reilly, Mohammed Bourdi, Michael F. Radonovich, John N Brady, John W. George, Lance R. Pohl · 发表于:Chemical Research in Toxicology · 年份:2002 · DOI:10.1021/tx0255976 · 被引用次数:357 · 研究领域:Drug-Induced Hepatotoxicity and Protection、Liver physiology and pathology、Drug Transport and Resistance Mechanisms

Hepatic injury induced by various toxic agents, including acetaminophen (APAP), has been attributed, in part, to the production of proinflammatory cytokines and other mediators by resident Kupffer cells within the liver. However, recent evidence from our laboratory has demonstrated that hepato-protective factors, such as interleukin (IL)-10 and cyclooxygenase-derived mediators, are also upregulated in response to hepatic damage to help protect against exacerbated injury, and Kupffer cells have been suggested to be a source of these modulatory factors. In other models, Kupffer cells also serve important regulatory functions in pathophysiological states of the liver. Therefore, we reevaluated the role of Kupffer cells in a murine model of APAP-induced liver injury using liposome-entrapped clodronate (liposome/clodronate) as an effective Kupffer cell-depleting agent. We show that in contrast to pretreatment of mice with a widely used macrophage inhibitor, gadolinium chloride, which did not deplete Kupffer cells but moderately protected against APAP-induced hepatotoxicity as reported previously, the intravenous injection of liposome/clodronate caused nearly complete elimination of Kupffer cells and significantly increased susceptibility to APAP-induced liver injury as compared with mice pretreated with empty liposomes. This increased susceptibility was apparently unrelated to the metabolism of APAP since liposome/clodronate pretreatment did not alter APAP-protein adduct levels. I...